ScarX Therapeutics Overview

  • Founded
  • 2012
Founded
  • Status
  • Out of Business
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Out of Business

ScarX Therapeutics General Information

Description

Developer of innovative therapeutics intended to address excessive dermal scarring. The company's therapeutics are used to produce a small molecule therapeutic drug with anti-fibrotic activity that reduce dermal scarring during wound healing and also development of a novel therapeutic products, enabling patients to have better post-surgical outcomes following cosmetic and reconstructive plastic surgeries.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Personal Products
Primary Office
  • 661 University Avenue
  • Suite 465
  • Toronto, Ontario M5G 1M1
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ScarX Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 11-Dec-2019 00.00 Completed Out of Business
3. Early Stage VC (Series A) 16-Feb-2016 000 00.00 Completed Clinical Trials - Phase 1
2. Grant 24-Jan-2013 $1M $1.7M Completed Pre-Clinical Trials
1. Early Stage VC 25-Sep-2012 $1.7M $1.7M Completed Pre-Clinical Trials
To view ScarX Therapeutics’s complete valuation and funding history, request access »

ScarX Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial